Korn Ferry KFY Life Sciences/Healthcare — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Korn Ferry in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Korn Ferry’s 10-Q, filed March 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Korn Ferry's life sciences/healthcare — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Korn Ferry's life sciences/healthcare — total revenue?
- Korn Ferry (KFY) reported life sciences/healthcare — total revenue of $121.53M in Q4 2025.
- How has Korn Ferry's life sciences/healthcare — total revenue changed year-over-year?
- Korn Ferry's life sciences/healthcare — total revenue increased by 2.7% year-over-year, from $118.36M to $121.53M.
- What is the long-term trend for Korn Ferry's life sciences/healthcare — total revenue?
- Over 4 years (2021 to 2025), Korn Ferry's life sciences/healthcare — total revenue has grown at a 7.5% compound annual growth rate (CAGR), from $355.67M to $475.78M.
- What does life sciences/healthcare — total revenue mean?
- This metric represents the total gross revenue generated by the Life Sciences and Healthcare business segment. It reflects the aggregate demand for organizational consulting, executive search, and talent acquisition services specifically tailored to clients within the healthcare and life sciences industries. Tracking this figure helps investors assess the company's market penetration and competitive positioning within this specialized vertical.